Journal article
Nutrition adequacy therapeutic enhancement in the critically ill: a randomized double‐blind, placebo‐controlled trial of the motilin receptor agonist camicinal (GSK962040): the NUTRIATE study
- Abstract:
-
Background
Camicinal is a novel, nonmacrolide, motilin receptor agonist that accelerates gastric emptying in critically ill patients with established feed intolerance. The primary question was whether the preemptive administration of camicinal increased the provision of enteral nutrition (EN) to critically ill patients with risk factors that predisposed to feed intolerance.
Methods
This was an international, multicenter, parallel‐group...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
GlaxoSmithKline
More from this funder
Bibliographic Details
- Publisher:
- Wiley Publisher's website
- Journal:
- Journal of Parenteral and Enteral Nutrition Journal website
- Volume:
- 42
- Issue:
- 5
- Pages:
- 949-959
- Publication date:
- 2017-12-28
- Acceptance date:
- 2017-10-16
- DOI:
- EISSN:
-
1941-2444
- ISSN:
-
0148-6071
- Pmid:
-
29957868
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:1033402
- UUID:
-
uuid:91af7d9e-62f8-4014-a8b0-2fca1553468c
- Local pid:
- pubs:1033402
- Source identifiers:
-
1033402
- Deposit date:
- 2019-07-18
Terms of use
- Copyright holder:
- American Society for Parenteral and Enteral Nutrition
- Copyright date:
- 2017
- Notes:
- © 2017 American Society for Parenteral and Enteral Nutrition.
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record